Showing results (221-230 of 250) with videos related to

Sort By:
Pageof 25
Annals of the Rheumatic Diseases|January 14, 2005
The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas: the wrist jointB Ejbjerg, F McQueen, M Lassere, et al.
Annals of the Rheumatic Diseases|January 14, 2005
The development of the EULAR-OMERACT rheumatoid arthritis MRI reference image atlasP Bird, P Conaghan, B Ejbjerg, et al.
The Journal of Rheumatology|May 22, 2001
Magnetic resonance imaging in rheumatoid arthritis: summary of OMERACT activities, current status, and plansP Conaghan, J Edmonds, P Emery, et al.
Journal of the American Chemical Society|September 6, 2008
Design, synthesis, and biological evaluation of platensimycin analogues with varying degrees of molecular complexityK C Nicolaou, Antonia F Stepan, Troy Lister, et al.
BMC Public Health|September 3, 2014
Field-testing of the rapid assessment of disability questionnaireManjula Marella, Lucy Busija, Fakir M Amirul Islam, et al.
Microbial Ecology|May 2, 2002
A cross-system comparison of bacterial and fungal biomass in detritus pools of headwater streamsS Findlay, J Tank, S Dye, et al.
The Journal of Organic Chemistry|January 14, 2012
Synthesis of 7-oxo-dihydrospiro[indazole-5,4'-piperidine] acetyl-CoA carboxylase inhibitorsScott W Bagley, James A Southers, Shawn Cabral, et al.
Human Molecular Genetics|June 21, 2014
Caenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for neuroprotective drug screening and identifies a SIR-2.1-independent action of resveratrolSudhanva S Kashyap, James R Johnson, Hannah V McCue, et al.
Nature Communications|November 29, 2023
Mechanisms of synthetic lethality between BRCA1/2 and 53BP1 deficiencies and DNA polymerase theta targetingGeorge E Ronson, Katarzyna Starowicz, Elizabeth J Anthony, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2013
Demonstration of the innate electrophilicity of 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptorHeather Eng, Raman Sharma, Thomas S McDonald, et al.
Pageof 25